Skip to content
TrialScanner

NCT06208215

RZ358 Treatment for Congenital Hyperinsulinism

Phase 3Active, not recruitingRZLTLead

Registry record

Lead sponsor
Rezolute
Conditions
Congenital Hyperinsulinism
Primary completion
Nov 14, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06208215 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06208215: RZ358 Treatment for Congenita... | TrialScanner